Product Details
Jyna Emtricitabine and Tenofovir Disoproxil Fumarate##
Emtricitabine; Tenofovir Disoproxil Fumarate200 mg; 300 mg
Tablet
ROA
Oral
Applicant Name
Jyna Pharma Ltd
NRN
C4-0479
Status
Active
Composition
Each film Coated Tablet contains: Emtricitabine 200 mg, Tenofovir Disoproxil Fumarate 300 mg equivalent to Tenofovir Disoproxil 245 mg This medicinal product contains: Lactose (Anhydrous) 145 mg in core and 8.40 mg (28.0 % of 30 mg) in the film coat of Lactose Monohydrate Excipients q.s.
ATC Code
J05AR03
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
Product Description
Film Coated Tablet. Blue colored, capsule shaped, film coated biconvex tablets, debossed with “LA49” on one side and plain on the other side "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS ARE INDICATED IN ANTIRETROVIRAL COMBINATION THERAPY FOR THE TREATMENT OF HIV-1 INFECTED ADULTS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS ARE ALSO INDICATED FOR THE TREATMENT OF HIV-1 INFECTED ADOLESCENTS, WITH NRTI RESISTANCE OR TOXICITIES PRECLUDING THE USE OF FIRST LINE AGENTS."
Manufacturer Name
Laurus Labs Limited
Manufacturer Country
INDIA
Approval Date
2021-05-07
Expiry Date
2026-05-06